Boston Scientific (BSX) Drug Pipeline
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Boston Scientific (MX:BSX) have in its pipeline
Boston Scientific MX:BSX is currently developing the following drugs: Agent Dcb 40 Mm, Therasphere Gbm, Therasphere Y-90 Glass Microsphere Therapy, Durvalumab Immunotherapy, Tremelimumab Immunotherapy, Therasphere Yttrium-90 Glass Microspheres, Conventional Transarterial Chemoembolization, Ekosonictm Endovascular System, Anticoagulation With Heparin, Agent Dcb, Ptca Balloon Catheter, Deep Brain Stimulation. These drug candidates are in various stages of clinical development as the company works toward FDA approval.